Not yet – but soon.
We recognize the importance of placebo-controlled studies as a way to demonstrate the efficacy of any new medication – including Banjo. We also realize that until we have credible, third-party verification of efficacy, most people will choose not to try Banjo. Clinical trials are therefore of great importance to us, and their completion is a high priority.
We plan to begin our first clinical trials in early 2011, and hope to complete at least two and as many as four such trials by 2012.
It seems likely that our first trial will center on fibromyalgia and that the second will focus on osteoarthritis. Ideally, we would like to sponsor at least two substantial trials for each condition.
Trials will be conducted by well-respected researchers at credible institutions.